ArticleFrontiers in pharmacology2019

Incretins and SGLT-2i Therapy of Type 2 Diabetes - Real Life Study of Their Therapeutic and Economic Effects.

Zornitsa Mitkova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.